4 | apricoxibIBA
04/2014
-
02/2011 |
3 | Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2014
-
02/2011 |
2 | Biomarkers (Surrogate Marker)IBA
04/2014
-
02/2011 |
2 | PlatinumIBA
04/2014
-
07/2007 |
2 | Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
09/2012
-
02/2011 |
2 | taxaneIBA
07/2007
-
08/2005 |
1 | Aurora Kinase AIBA
01/2021 |
1 | LY3295668 erbumineIBA
01/2021 |
1 | Phosphotransferases (Kinase)IBA
11/2014 |
1 | Mitogen-Activated Protein Kinase 7IBA
11/2014 |
1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2014 |
1 | ErbB Receptors (EGF Receptor)IBA
04/2014 |
1 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
05/2013 |
1 | Proteins (Proteins, Gene)FDA Link
05/2013 |
1 | Lenalidomide (CC 5013)FDA Link
05/2013 |
1 | Bortezomib (Velcade)FDA Link
05/2013 |
1 | GemcitabineFDA Link
09/2012 |
1 | Antineoplastic Agents (Antineoplastics)IBA
09/2012 |
1 | ProstaglandinsIBA
02/2011 |
1 | 7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA
02/2011 |
1 | CreatinineIBA
02/2011 |
1 | Carboplatin (JM8)FDA LinkGeneric
07/2007 |
1 | epothilone B (EPO906)IBA
07/2007 |
1 | lonafarnib (SCH 66336)IBA
08/2005 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
08/2005 |
1 | Farnesyltranstransferase (Farnesyltransferase)IBA
08/2005 |
1 | Temozolomide (Temodar)FDA LinkGeneric
02/2003 |